Migraines are a neurological condition characterized by intense, throbbing headaches often accompanied by nausea, sensitivity to light and sound, and visual disturbances. Affecting about 1 in 6 people in the U.S., migraines can vary in severity and frequently disrupt daily life. Recent advances in treatment have brought new relief options, particularly through injectable therapies. Medications like Botox work by blocking neurotransmitters involved in migraine attacks, while monoclonal antibodies (mAbs) target CGRP — a naturally occurring peptide in the body that dilates blood vessels and is found in higher levels in migraine sufferers. A recent study by the American Headache Society found Botox to be a safe and effective treatment for chronic migraine, with nearly 75% of patients reporting fewer or less severe headaches each month.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.